All In MedTech

FDA Clearance Tracker · P970017

SAHARA CLINICAL BONE SONOMETER

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Mar 12, 1998 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

The decision

FDA number
P970017
Device name
SAHARA CLINICAL BONE SONOMETER
Applicant
Hologic, Inc.
Applicant location
Bedford, MA
Received
Apr 7, 1997
Decided
Mar 12, 1998
Decision
Approved (reclassified)
Supplements
1 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 892.1180

Every decision under product code MUA

FDA's approval statement

As written in FDA's record.

Approval for the Sahara Clinical Bone Sonometer. The intended use of the Sahara Clinical Bone Sonometer is to: Perform a quantitative ultrasound measurement of the calcaneus (heel bone), the results of which can be used in conjunction with other clincal risk factors as an aid to the physician in the diagnosis of osteoporosis and medical conditions leading to reduced bone density, and ultimately in the determination of fracture risk. Sahara measures the speed of sound (SOS, in m/s) and broadband ultrasonic attenuation (BUA, in dB/MHz) of an ultrasound beam passed throught he calcaneus, and combines these results linearly to obtain the Quantitative Ultrasound Index (QUI). The output is also expressed as a T-score and as an estimate of the Bone Mineral Density (BMD, in g/cm2) of the calcaneus as measured by Dual Energy X-ray Absorpiometry (DXA).

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code MUA (Bone sonometer).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Hologic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.